Search Results - "Merkel, P A"

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by Yates, M, Watts, R A, Bajema, I M, Cid, M C, Crestani, B, Hauser, T, Hellmich, B, Holle, J U, Laudien, M, Little, M A, Luqmani, R A, Mahr, A, Merkel, P A, Mills, J, Mooney, J, Segelmark, M, Tesar, V, Westman, K, Vaglio, A, Yalçındağ, N, Jayne, D R, Mukhtyar, C

“…In this article, the 2009 European League Against Rheumatism (EULAR) recommendations for the management of antineutrophil cytoplasmic antibody…”
Get more information

EULAR recommendations for the management of large vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of large vessel vasculitis. An expert group (10 rheumatologists, 3…”
Get more information

EULAR recommendations for the management of primary small and medium vessel vasculitis by Mukhtyar, C, Guillevin, L, Cid, M C, Dasgupta, B, de Groot, K, Gross, W, Hauser, T, Hellmich, B, Jayne, D, Kallenberg, C G M, Merkel, P A, Raspe, H, Salvarani, C, Scott, D G I, Stegeman, C, Watts, R, Westman, K, Witter, J, Yazici, H, Luqmani, R

“…To develop European League Against Rheumatism (EULAR) recommendations for the management of small and medium vessel vasculitis. An expert group (consisting of…”
Get more information

Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force by Mukhtyar, C, Flossmann, O, Hellmich, B, Bacon, P, Cid, M, Cohen-Tervaert, J W, Gross, W L, Guillevin, L, Jayne, D, Mahr, A, Merkel, P A, Raspe, H, Scott, D, Witter, J, Yazici, H, Luqmani, R A

“…We undertook a systematic literature review as a background to the European League Against Rheumatism (EULAR) recommendations for conducting clinical trials in…”
Get more information

Nomenclature and classification of vasculitis – update on the ACR/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS) by Luqmani, R. A., Suppiah, R., Grayson, P. C., Merkel, P. A., Watts, R.

“…Summary Classification of vasculitis remains unsatisfactory. This is largely because the pathogenetic mechanisms of this family of related disorders have not…”
Get full text

Cardiovascular risk factors and incident giant cell arteritis: a population-based cohort study by Tomasson, G, Bjornsson, J, Zhang, Y, Gudnason, V, Merkel, PA

“…Objective: To assess the strength of the effect of cardiovascular risk factors on the incidence of giant cell arteritis (GCA) in a general population context…”
Get full text

Clinical Outcomes of Remission Induction Therapy for Severe Antineutrophil Cytoplasmic Antibody–Associated Vasculitis by Miloslavsky, E. M., Specks, U., Merkel, P. A., Seo, P., Spiera, R., Langford, C. A., Hoffman, G. S., Kallenberg, C. G. M., St.Clair, E. W., Tchao, N. K., Viviano, L., Ding, L., Sejismundo, L. P., Mieras, K., Iklé, D., Jepson, B., Mueller, M., Brunetta, P., Allen, N. B., Fervenza, F. C., Geetha, D., Keogh, K., Kissin, E. Y., Monach, P. A., Peikert, T., Stegeman, C., Ytterberg, S. R., Stone, J. H.

“…Objective To evaluate the reasons that complete remission is not achieved or maintained with original treatment in some patients with antineutrophil…”
Get full text

Patterns and predictors of change in outcome measures in clinical trials in scleroderma: An individual patient meta-analysis of 629 subjects with diffuse cutaneous systemic sclerosis by Merkel, P. A., Silliman, N. P., Clements, P. J., Denton, C. P., Furst, D. E., Mayes, M. D., Pope, J. E., Polisson, R. P., Streisand, J. B., Seibold, J. R.

“…Objective To examine the range and responsiveness to change of clinical outcome measures and study predictors of clinical response in patients with diffuse…”
Get full text

Clinicians' perspective on key domains in ANCA-associated vasculitis: a Delphi exercise by Milman, N, Boonen, A, Tugwell, P, Merkel, PA

“…Objectives: The existing set of outcomes for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) needs to incorporate views of outcome…”
Get full text

Development of a provisional core set of response measures for clinical trials of systemic sclerosis by Khanna, D, Lovell, D J, Giannini, E, Clements, P J, Merkel, P A, Seibold, J R, Matucci-Cerinic, M, Denton, C P, Mayes, M D, Steen, V D, Varga, J, Furst, D E

“…To develop a provisional core set of response measures for clinical trials of systemic sclerosis (SSc). The Scleroderma Clinical Trials Consortium (SCTC)…”
Get more information

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis by Merkel, P A, Cuthbertson, D D, Hellmich, B, Hoffman, G S, Jayne, D R W, Kallenberg, C G M, Krischer, J P, Luqmani, R, Mahr, A D, Matteson, E L, Specks, U, Stone, J H

“…Currently, several different instruments are used to measure disease activity and extent in clinical trials of anti-neutrophil cytoplasmic autoantibody…”
Get more information

Epidemiology of Wegener's granulomatosis : Lessons from descriptive studies and analyses of genetic and environmental risk determinants by MAHR, A. D, NEOGI, T, MERKEL, P. A

“…During the past 15 years, the epidemiology of Wegener's granulomatosis (WG) has become better understood. Descriptive epidemiological studies carried out…”
Get full text

Pulmonary function tests, interstitial lung disease and lung function decline in outpatients with classic and clinically amyopathic dermatomyositis by George, M.D., Shah, R., Kreider, M., Miller, W.T., Merkel, P.A., Werth, V.P.

Get full text

Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies by CHOI, Hyon K, SIMIN LIU, MERKEL, Peter A, COLDITZ, Graham A, NILES, John L

“…OBJECTIVE: The diagnostic value of tests for antimyeloperoxidase antibodies (anti-MPO) for systemic vasculitis is less established than that for cytoplasmic…”
Get full text

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) by Mohammad, A J, Hot, A, Arndt, F, Moosig, F, Guerry, M-J, Amudala, N, Smith, R, Sivasothy, P, Guillevin, L, Merkel, P A, Jayne, D R W

“…Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional…”
Get more information

2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides by Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., Hoffman, G. S., Jayne, D. R., Kallenberg, C. G. M., Lamprecht, P., Langford, C. A., Luqmani, R. A., Mahr, A. D., Matteson, E. L., Merkel, P. A., Ozen, S., Pusey, C. D., Rasmussen, N., Rees, A. J., Scott, D. G. I., Specks, U., Stone, J. H., Takahashi, K., Watts, R. A.

Get full text

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis-a meta-analysis by Tomasson, Gunnar, Grayson, Peter C., Mahr, Alfred D., LaValley, Michael, Merkel, Peter A.

“…Objective. The value of repeated ANCA measurements among patients with an established diagnosis of ANCA-associated vasculitis (AAV) remains controversial. The…”
Get full text

Recombinant human relaxin in the treatment of scleroderma : A randomized, double-blind, placebo-controlled trial by SEIBOLD, J. R, KORN, J. H, COLLIER, D, WIGLEY, F. M, MERKEL, P. A, CSUKA, M. E, HSU, V, ROCCO, S, ERIKSON, M, HANNIGAN, J, HARKONEN, W. S, SANDERS, M. E, SIMMS, R, CLEMENTS, P. J, MORELAND, L. W, MAYES, M. D, FURST, D. E, ROTHFIELD, N, STEEN, V, WEISMAN, M

“…Relaxin is a pregnancy-related hormone that has tissue remodeling and antifibrotic effects. Systemic sclerosis (scleroderma) is characterized by fibrosis of…”
Get full text

A disease-associated gene desert directs macrophage inflammation through ETS2 by Stankey, C. T., Bourges, C., Haag, L. M., Turner-Stokes, T., Piedade, A. P., Palmer-Jones, C., Papa, I., Silva dos Santos, M., Zhang, Q., Cameron, A. J., Legrini, A., Zhang, T., Wood, C. S., New, F. N., Randzavola, L. O., Speidel, L., Brown, A. C., Hall, A., Saffioti, F., Parkes, E. C., Edwards, W., Direskeneli, H., Grayson, P. C., Jiang, L., Merkel, P. A., Saruhan-Direskeneli, G., Sawalha, A. H., Tombetti, E., Quaglia, A., Thorburn, D., Knight, J. C., Rochford, A. P., Murray, C. D., Divakar, P., Green, M., Nye, E., MacRae, J. I., Jamieson, N. B., Skoglund, P., Cader, M. Z., Wallace, C., Thomas, D. C., Lee, J. C.

“…Increasing rates of autoimmune and inflammatory disease present a burgeoning threat to human health 1 . This is compounded by the limited efficacy of available…”
Get full text

ANCA-associated small vessel vasculitis presenting with ischemic optic neuropathy by DURAN, E, MERKEL, P. A, SWEET, S, SWAN, N, BABIKIAN, V. L

Get full text